RE:RE:RE:RE:RE:RE:RE:RE:So - Buy TRX Now or$20USD would put us at $3.80 CAD with currency conversion in there. In addiion to the aformentioned drugs, Aralez will have Bilastine and Yosprala coming online this year, plus whatever the warchest buys; so a doubling in 2016 isn't unreasonable depending on market sentiment. Assuming we hit the ground running somewhere between $7 and $11, I think $20 by the end of the year (assuming the market doesn't crater) is a possibility. This is why I think it would be in Depomed's best interest to make an offer sooner than later, but my sentiment towards ARLZ will be the same as it was for TRX - I want some real growth there before Adams pulls the trigger on a merger or sale. Need to see some real green here.